Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. Niraparib

   Takeda

   Ovarian Cancer

   phase 2 · small molecule · completed

   2 trials →

2. Niraparib-Bevacizumab

   Takeda

   Platinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP Inhibitor

   phase 2 · small molecule · active

   1 trial →

3. Nivolumab

   Adaptive Biotechnologies Corp

   Bladder Cancer

   phase 2 · small molecule · completed

   1 trial →

4. Nivolumab

   Mereo BioPharma Group plc

   Ovarian Cancer

   phase 2 · small molecule · active

   1 trial →

5. Nivolumab

   United Therapeutics Europe Ltd

   Metastatic Uveal Melanoma

   phase 2 · small molecule · completed

   1 trial →

6. Nivolumab

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Advanced Biliary Tract Cancer(BTC)

   phase 2 · small molecule · active

   1 trial →

7. Nivolumab

   Bristol-Myers Squibb

   Prostate Cancer

   phase 2 · mab · completed

   1 trial →

8. Nivolumab

   Bristol-Myers Squibb

   Hepatocellular Carcinoma

   phase 2 · mab · completed

   1 trial →

9. Nivolumab & Ipilimumab

   The First People's Hospital of Lianyungang

   Lung Cancer - Non Small Cell

   phase 2 · small molecule · active

   1 trial →

10. Nivolumab Injection [Opdivo]

    The First People's Hospital of Lianyungang

    Neoplasms

    phase 2 · small molecule · active

    1 trial →

11. OBINUTUZUMAB, Zanubrutinib

    BeiGene

    Relapsed/Refractory Follicular Lymphoma

    phase 2 · small molecule · active

    1 trial →

12. OGX-011

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 2 · mab · completed

    1 trial →

13. OLAPARIB, BEVACIZUMAB

    The George Institute

    Advanced FIGO Stage III‐IV High Grade Serous or Endometrioid Ovarian, Fallopian Tube, or Peritoneal Cancer

    phase 2 · small molecule · active

    1 trial →

14. OMEPRAZOLE , ACETYLSALICYLIC ACID

    The George Institute

    Colorectal cancer

    phase 2 · small molecule · active

    1 trial →

15. OMP-59R5

    Mereo BioPharma Group plc

    Stage IV Small Cell Lung Cancer

    phase 2 · small molecule · terminated

    1 trial →

16. OMP-59R5

    Mereo BioPharma Group plc

    Stage IV Pancreatic Cancer

    phase 2 · small molecule · completed

    1 trial →

17. OMTX705-004

    Lacuna Pharma Pty Ltd

    Advanced/metastatic colorectal cancer

    phase 2 · small molecule · active

    1 trial →

18. OMTX705-005

    Lacuna Pharma Pty Ltd

    Advanced/Metastatic Non-squamous Non-Small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

19. ONO-4578

    Ono Pharmaceutical Co.,

    Colorectal Cancer

    phase 2 · small molecule · active

    1 trial →

20. ONO-4578-10

    Lacuna Pharma Pty Ltd

    PD-L1 positive advanced colorectal cancer

    phase 2 · small molecule · active

    1 trial →

21. OP-1250

    Olema Pharmaceuticals

    Hormone Receptor Positive Breast Carcinoma

    phase 2 · small molecule · completed

    1 trial →

22. OPDIVO 10 mg/mL concentrate for solution for infusion.

    Ningbo Cancer Hospital

    Early stage triple negative breast cancer

    phase 2 · small molecule · active

    1 trial →

23. OPDIVO 10 mg/mL concentrate for solution for infusion.

    The George Institute

    Relapsing/Refractory ALK+ Anaplastic Large cell Lymphoma

    phase 2 · small molecule · active

    1 trial →

24. OPDIVO for Unresectable locally advanced o…

    Tour Hekla

    Unresectable locally advanced or metastatic urothelial cancer

    phase 2 · small molecule · active

    1 trial →

25. OPDIVO for advanced or metastatic gastrooe…

    Fondazione Telethon ETS

    advanced or metastatic gastrooesophageal carcinoma HER2 negative and ARID1A mutated

    phase 2 · small molecule · active

    1 trial →

26. OPM-101

    Chongqing Precision Biotech Co., Ltd

    Advanced Melanoma

    phase 2 · small molecule · active

    1 trial →

27. ORI2025-16

    The George Institute

    Colon cancer

    phase 2 · small molecule · active

    1 trial →

28. ORIC-114

    Topiloric/Uriadec

    Solid Tumors

    phase 2 · small molecule · active

    1 trial →

29. ORIC-114

    Topiloric/Uriadec

    Solid Tumors

    phase 2 · small molecule · active

    1 trial →

30. Obatoclax

    Teva Pharma GmbH

    Extensive-stage Small Cell Lung Cancer

    phase 2 · small molecule · completed

    1 trial →

31. Obatoclax Mesylate

    Teva Pharma GmbH

    Metastatic Melanoma

    phase 2 · small molecule · terminated

    1 trial →

32. Obatoclax mesylate

    Teva Pharma GmbH

    Lymphoma, Follicular

    phase 2 · small molecule · completed

    1 trial →

33. Obatoclax mesylate

    Teva Pharma GmbH

    Mantle-Cell Lymphoma

    phase 2 · small molecule · completed

    1 trial →

34. Obatoclax mesylate (GX15-070MS)

    Teva Pharma GmbH

    Hodgkin's Lymphoma

    phase 2 · small molecule · completed

    1 trial →

35. Obatoclax mesylate 250 ml

    Teva Pharma GmbH

    Lung Cancer

    phase 2 · small molecule · completed

    1 trial →

36. Obecabtagene Autoleucel

    Autolus GmbH

    Acute Lymphoblastic Leukemia

    phase 2 · small molecule · active

    1 trial →

37. Obecabtagene autoleucel

    Autolus GmbH

    Acute Lymphocytic Leukemia (ALL)

    phase 2 · small molecule · active

    1 trial →

38. Obinutuzumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Marginal Zone Lymphoma

    phase 2 · small molecule · active

    1 trial →

39. Obinutuzumab

    The First People's Hospital of Lianyungang

    Large B-cell Lymphoma

    phase 2 · small molecule · active

    1 trial →

40. Obinutuzumab

    Adaptive Biotechnologies Corp

    Mantle Cell Lymphoma

    phase 2 · mab · active

    1 trial →

41. Odomzo 200 mg hard capsules

    Fondazione Telethon ETS

    locally advanced basal cell carcinoma

    phase 2 · small molecule · active

    1 trial →

42. Odronextamab

    Regeneron UK Limited

    Recurrent Diffuse Large B-Cell Lymphoma

    phase 2 · mab · active

    1 trial →

43. Odronextamab

    Regeneron UK Limited

    B-cell Non-Hodgkin Lymphoma (B-NHL)

    phase 2 · small molecule · active

    2 trials →

44. Odronextamab

    Regeneron UK Limited

    Follicular Lymphoma

    phase 2 · mab · active

    1 trial →

45. Olaparib

    United Therapeutics Europe Ltd

    Bile Duct Adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

46. Olaparib Continuous (28-Day cycle) 300 mg BD.

    AstraZeneca

    Metastatic Triple Negative Breast Cancer

    phase 2 · small molecule · active

    1 trial →

47. Olutasidenib

    RIGEL PHARMACEUTICALS INC

    Acute Myeloid Leukemia

    phase 2 · small molecule · active

    1 trial →

48. Olutasidenib

    RIGEL PHARMACEUTICALS INC

    Chronic Myelomonocytic Leukemia

    phase 2 · small molecule · terminated

    1 trial →

Frequently asked questions